Treat this 10-month-old infant with azithromycin for presumed pertussis
Based on the clinical presentation of paroxysmal cough worsening at night, post-tussive vomiting, and thick nasal secretions in a 10-month-old, this infant should be treated with azithromycin 10 mg/kg on day 1, followed by 5 mg/kg daily on days 2-5. 1
Clinical Diagnosis
This infant meets clinical criteria highly suggestive of pertussis:
- Paroxysmal cough (recurrent prolonged coughing episodes with inability to breathe during spells)
- Post-tussive vomiting (vomiting induced by coughing) - a key diagnostic feature in children 2
- Nocturnal worsening - paroxysms characteristically occur more frequently at night 1
- Age vulnerability - infants <12 months are at highest risk for severe complications and death 1
The CHEST 2019 guidelines specifically recommend assessing for paroxysmal cough, post-tussive vomiting, and inspiratory whooping in children with acute cough (<4 weeks), noting that post-tussive vomiting is particularly suggestive of pertussis 2.
Treatment Regimen
For this 10-month-old infant, administer azithromycin:
- Day 1: 10 mg/kg (maximum 500 mg)
- Days 2-5: 5 mg/kg daily (maximum 250 mg) 1
Why Azithromycin?
Azithromycin is preferred over erythromycin because it:
- Has equal effectiveness against Bordetella pertussis 1
- Causes fewer gastrointestinal side effects and better tolerability 1
- Requires only once-daily dosing for 5 days (versus 4 times daily for 14 days with erythromycin) 1
- Does not inhibit cytochrome P450 enzymes, avoiding drug interactions 1
- Has no association with infantile hypertrophic pyloric stenosis (IHPS) in this age group 1
Critical Timing Considerations
Antibiotics must be started early - while they eradicate B. pertussis from the nasopharynx and reduce transmission, they have limited effect on symptom duration if started late in the illness course 1. However, treatment is still indicated to:
- Reduce the infectious period (untreated infants can remain culture-positive for >6 weeks) 1
- Prevent transmission to vulnerable contacts
- Potentially reduce severity if caught early 1
Household Contact Management
All close household contacts should receive prophylaxis with the same azithromycin regimen (age-adjusted dosing) within 21 days of cough onset to prevent secondary cases 1. This is particularly critical because:
- Secondary attack rates exceed 80% among susceptible persons 1
- Adolescents and adults often have atypical presentations and serve as the reservoir 1, 3
Monitoring for Complications
This infant requires close monitoring for severe pertussis complications, as infants <12 months have the highest risk for:
- Apnea (can be the initial presentation) 1, 4
- Pneumonia (primary or secondary bacterial)
- Seizures and hypoxic encephalopathy
- Respiratory failure 5, 4
Watch for peripheral hyperleucocytosis with lymphocytosis, which indicates high risk for severe disease 4, 6.
Common Pitfalls to Avoid
- Don't wait for laboratory confirmation - treat based on clinical suspicion, as PCR and culture take time 2, 4
- Don't use erythromycin - it has worse side effects and requires 14 days of treatment 1
- Don't assume vaccination prevents disease - immunity wanes, and partially immunized infants can still develop pertussis 7, 6
- Don't overlook household contacts - they are the primary source of infection for infants and must receive prophylaxis 1, 4
Alternative Considerations
If macrolide resistance is suspected (increasingly reported, particularly in China 7, 8) or if the infant has a macrolide allergy, trimethoprim-sulfamethoxazole can be used as an alternative for infants >2 months old 1, 7. However, azithromycin remains first-line in the absence of these concerns.